{"questions":[{"id":"open_question-217fd038-ebbf-495a-96ec-9358c36f9bdc","artifact_type":"open_question","title":"Mechanistic understanding**: How does amyloid disrupt DMN function?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:49.616654+00:00","updated_at":"2026-04-26T03:29:49.616654+00:00"},{"id":"open_question-c5f4f361-bccc-45f0-9fd0-1d6c00252f16","artifact_type":"open_question","title":"Mechanistic understanding**: How does alpha-synuclein spread through autonomic networks?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:49.086613+00:00","updated_at":"2026-04-26T03:29:49.086613+00:00"},{"id":"open_question-9d844f47-a090-4576-ad91-8be549959d63","artifact_type":"open_question","title":"How does the spreading pattern correlate with clinical progression?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:42.786604+00:00","updated_at":"2026-04-26T03:25:42.786604+00:00"},{"id":"open_question-6ce14522-f4f2-48cf-a458-360ed896a924","artifact_type":"open_question","title":"How do environmental toxins interact with mitochondrial pathways?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:43.407370+00:00","updated_at":"2026-04-26T03:25:43.407370+00:00"},{"id":"open_question-c939f411-d7b5-46c7-af85-42be1201e71d","artifact_type":"open_question","title":"Which combination of biomarkers provides optimal prodromal detection?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:43.477777+00:00","updated_at":"2026-04-26T03:25:43.477777+00:00"},{"id":"open_question-brain-regions-amygdala-e6565094","artifact_type":"open_question","title":"Single-nucleus sequencing","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-brain-regions-amygdala-c3aa8499","artifact_type":"open_question","title":"Light-sheet microscopy","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-brain-regions-amygdala-edeac57f","artifact_type":"open_question","title":"AI-assisted diagnosis","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-brain-regions-amygdala-6737ef5a","artifact_type":"open_question","title":"Personalized medicine","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-5d76508a-65b5-4f78-bb99-ed606db1615c","artifact_type":"open_question","title":"What triggers the initial misfolding of alpha-synuclein in sporadic PD?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:42.400667+00:00","updated_at":"2026-04-26T03:25:42.400667+00:00"},{"id":"open_question-b09ea146-2bdc-48a0-a619-b7a36b9d045c","artifact_type":"open_question","title":"Can targeting propagation halt disease progression in established PD?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:42.967148+00:00","updated_at":"2026-04-26T03:25:42.967148+00:00"},{"id":"open_question-13cc4c56-4e84-4e1b-856b-175f66f530ae","artifact_type":"open_question","title":"What is the normal physiological function of LRRK2, and how do pathogenic mutations disrupt it?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:43.065951+00:00","updated_at":"2026-04-26T03:25:43.065951+00:00"},{"id":"open_question-14d10ec2-ac36-41f3-8550-6a0239bdc873","artifact_type":"open_question","title":"How do GBA mutations modify alpha-synuclein pathology and treatment response?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:43.135954+00:00","updated_at":"2026-04-26T03:25:43.135954+00:00"},{"id":"open_question-0c2deb0d-4057-4421-818e-f0892d5ff199","artifact_type":"open_question","title":"Can gene-specific therapies be developed for different genetic subtypes?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:43.206070+00:00","updated_at":"2026-04-26T03:25:43.206070+00:00"},{"id":"open_question-c3ce6b15-edee-4627-b2d3-cfd75a9a692d","artifact_type":"open_question","title":"What is the relative contribution of mitochondrial dysfunction to dopaminergic neuron loss?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:43.272462+00:00","updated_at":"2026-04-26T03:25:43.272462+00:00"},{"id":"open_question-ac0f3f39-cc4e-4d7c-ad45-5cdb4525b8d1","artifact_type":"open_question","title":"Can pharmacological activation of mitophagy compensate for PINK1/PARKIN deficiency?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:43.338368+00:00","updated_at":"2026-04-26T03:25:43.338368+00:00"},{"id":"open_question-f5356424-1b4c-4fa2-91e0-207d2b3eb418","artifact_type":"open_question","title":"What is the timeline from prodromal to clinical PD diagnosis?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:43.548776+00:00","updated_at":"2026-04-26T03:25:43.548776+00:00"},{"id":"open_question-90cfbb93-85c2-49c2-ac79-cf2517638833","artifact_type":"open_question","title":"Can prodromal intervention prevent progression to overt PD?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:43.624780+00:00","updated_at":"2026-04-26T03:25:43.624780+00:00"},{"id":"open_question-ddeebe1a-d450-4a57-baad-e1d29d27ad47","artifact_type":"open_question","title":"What determines whether a patient develops tau versus TDP-43 pathology?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:43.698310+00:00","updated_at":"2026-04-26T03:25:43.698310+00:00"},{"id":"open_question-c2de4b0f-e65f-4772-9f03-0f3b6c23c9dc","artifact_type":"open_question","title":"How do the different subtypes (bvFTD, svPPA, nfPPA) relate to specific proteinopathies?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:43.776672+00:00","updated_at":"2026-04-26T03:25:43.776672+00:00"},{"id":"open_question-a3bd5119-5ad9-4300-b15a-bb7e982db06c","artifact_type":"open_question","title":"What is the normal physiological function of progranulin in the brain?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:44.061589+00:00","updated_at":"2026-04-26T03:25:44.061589+00:00"},{"id":"open_question-f6665254-8b9c-43f5-8430-b686ce7e59d6","artifact_type":"open_question","title":"Can tau-targeted therapies benefit FTD patients with tau pathology?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:43.944836+00:00","updated_at":"2026-04-26T03:25:43.944836+00:00"},{"id":"open_question-4d7eea55-4c09-450b-857a-35681665b5da","artifact_type":"open_question","title":"Can progranulin replacement or upregulation restore function?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:44.214623+00:00","updated_at":"2026-04-26T03:25:44.214623+00:00"},{"id":"open_question-315ffa66-42b8-489f-a524-c96231bc9202","artifact_type":"open_question","title":"How does progranulin deficiency lead to selective neuronal vulnerability?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:44.137060+00:00","updated_at":"2026-04-26T03:25:44.137060+00:00"},{"id":"open_question-36bb66b8-f132-4d98-b542-8af693d8ffe7","artifact_type":"open_question","title":"What modifies the phenotype between FTD, ALS, and FTD-ALS?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:44.302286+00:00","updated_at":"2026-04-26T03:25:44.302286+00:00"},{"id":"open_question-622d9a1c-ecab-4340-92b7-0366d4d9dbef","artifact_type":"open_question","title":"How do dipeptide repeats contribute to neurodegeneration in FTD?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:44.379590+00:00","updated_at":"2026-04-26T03:25:44.379590+00:00"},{"id":"open_question-62128608-cfb7-45d8-8a43-2406957817b4","artifact_type":"open_question","title":"Can targeting RNA foci or dipeptide repeats provide therapeutic benefit?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:44.456881+00:00","updated_at":"2026-04-26T03:25:44.456881+00:00"},{"id":"open_question-354474db-9fb1-465c-bd65-04af925f8b1b","artifact_type":"open_question","title":"What fluid biomarkers distinguish FTD subtypes?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:44.528510+00:00","updated_at":"2026-04-26T03:25:44.528510+00:00"},{"id":"open_question-f5cf90ae-61d4-4038-995c-42cfde023298","artifact_type":"open_question","title":"How can genetic carriers be identified before symptom onset?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:44.592835+00:00","updated_at":"2026-04-26T03:25:44.592835+00:00"},{"id":"open_question-262f0de3-20ff-49df-acd8-2405e4c7e081","artifact_type":"open_question","title":"What is the optimal combination of biomarkers for clinical trials?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:44.658642+00:00","updated_at":"2026-04-26T03:25:44.658642+00:00"},{"id":"open_question-0adebbdb-4046-43c8-a516-bd727bae3c0c","artifact_type":"open_question","title":"What are the precise molecular switches that determine pathology type?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:55.397058+00:00","updated_at":"2026-04-26T03:28:55.397058+00:00"},{"id":"open_question-3c33aeb4-dd95-4201-abfa-3d69f0b8a163","artifact_type":"open_question","title":"How do genetic modifiers influence fate decisions?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:55.451973+00:00","updated_at":"2026-04-26T03:28:55.451973+00:00"},{"id":"open_question-a080ca47-338f-430e-b60e-46cc8ef99809","artifact_type":"open_question","title":"Can we intervene to redirect pathology type?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:55.508570+00:00","updated_at":"2026-04-26T03:28:55.508570+00:00"},{"id":"open_question-b589cb19-9188-40dd-8303-e97ff3102a44","artifact_type":"open_question","title":"What role does neuronal activity play in pathology selection?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:55.559505+00:00","updated_at":"2026-04-26T03:28:55.559505+00:00"},{"id":"open_question-bff1a0d2-4a26-4615-b7c7-4d1deac81c99","artifact_type":"open_question","title":"Why have many neuroprotective phase II/III ALS trials failed despite strong preclinical rationale?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:26.381305+00:00","updated_at":"2026-04-26T03:27:26.381305+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-dd941dde","artifact_type":"open_question","title":"Cell Type Decomposition","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-dd9c3bac","artifact_type":"open_question","title":"Neuronal Subtypes","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-1f7e6f61","artifact_type":"open_question","title":"Glial Cell Populations","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-18fef137","artifact_type":"open_question","title":"Epigenomic Data","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-740b07f4","artifact_type":"open_question","title":"Metabolomics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-f2b2d1ab","artifact_type":"open_question","title":"Prenatal to Adult Trajectories","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-0d27009e","artifact_type":"open_question","title":"Developmental Disorders","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-195cbbfd","artifact_type":"open_question","title":"Critical Periods","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-3f265739","artifact_type":"open_question","title":"Alzheimer's Disease","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-83f72f57","artifact_type":"open_question","title":"Parkinson's Disease","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-85ce6aca","artifact_type":"open_question","title":"Aging Consortium","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-53afcb5e","artifact_type":"open_question","title":"Spatial Transcriptomics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-allen-human-brain-atlas-9a6da6f9","artifact_type":"open_question","title":"Interactive Visualizations","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-resources-b1892ec2","artifact_type":"open_question","title":"iPSC Banks:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-resources-20cb6df6","artifact_type":"open_question","title":"Single-Cell Atlas:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-resources-d41264cf","artifact_type":"open_question","title":"Longitudinal Cohorts:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-resources-5f58a796","artifact_type":"open_question","title":"Open Science Platforms:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-gaps-blood-based-biomarkers-early-detection-3cf4c589","artifact_type":"open_question","title":"Single-molecule array (Simoa)","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-gaps-blood-based-biomarkers-early-detection-bbb50604","artifact_type":"open_question","title":"Mass spectrometry","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-gaps-blood-based-biomarkers-early-detection-8ea774e9","artifact_type":"open_question","title":"Multiplex platforms","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-gaps-blood-based-biomarkers-early-detection-32193239","artifact_type":"open_question","title":"Point-of-care devices","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-proteome-atlas-neurodegenerative-diseases-5215b909","artifact_type":"open_question","title":"Single-cell proteomics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-proteome-atlas-neurodegenerative-diseases-2099681e","artifact_type":"open_question","title":"Spatial proteomics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-proteome-atlas-neurodegenerative-diseases-f7ef6ada","artifact_type":"open_question","title":"Longitudinal proteomics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-proteome-atlas-neurodegenerative-diseases-e8785d22","artifact_type":"open_question","title":"Integration with genomics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-datasets-proteome-atlas-neurodegenerative-diseases-359a20fa","artifact_type":"open_question","title":"Multi-omics integration","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-circuits-central-autonomic-network-e52cf1d2","artifact_type":"open_question","title":"Targeted therapies","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-circuits-central-autonomic-network-24c5bcee","artifact_type":"open_question","title":"Biomarker development","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-circuits-central-autonomic-network-29081d9b","artifact_type":"open_question","title":"Early detection","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-circuits-central-autonomic-network-836cfc66","artifact_type":"open_question","title":"Mechanistic understanding","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-circuits-central-autonomic-network-6737ef5a","artifact_type":"open_question","title":"Personalized medicine","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-organizations-psp-italy-24c5bcee","artifact_type":"open_question","title":"Biomarker development","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-organizations-psp-italy-28be74de","artifact_type":"open_question","title":"Disease-modifying trials","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-organizations-psp-italy-290a019c","artifact_type":"open_question","title":"Digital phenotyping","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-organizations-cognicann-99297404","artifact_type":"open_question","title":"Advance CGC-100 to clinical trials","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-organizations-cognicann-3a5562f8","artifact_type":"open_question","title":"Expand pipeline","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-organizations-cognicann-fc8f88f6","artifact_type":"open_question","title":"Strategic partnerships","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-organizations-cognicann-dcf69526","artifact_type":"open_question","title":"Geographic expansion","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-organizations-cognicann-bdd72312","artifact_type":"open_question","title":"Acquisition opportunities","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-circuits-default-mode-network-836cfc66","artifact_type":"open_question","title":"Mechanistic understanding","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-circuits-default-mode-network-24c5bcee","artifact_type":"open_question","title":"Biomarker development","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-circuits-default-mode-network-02448326","artifact_type":"open_question","title":"Treatment targeting","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-circuits-default-mode-network-d35ef5ad","artifact_type":"open_question","title":"Individual variation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-circuits-default-mode-network-2b891ca9","artifact_type":"open_question","title":"Network repair","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"}],"total":79,"limit":100,"offset":0,"returned":79,"sort":"importance_elo","field":"other"}